Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;69 Suppl 1(Suppl 1):S34-S45.
doi: 10.1016/j.ihj.2016.12.012. Epub 2017 Jan 6.

Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum

Padmajan Sabin  1 , Alummoottil George Koshy  1 , Prabha Nini Gupta  2 , Pattu Valappil Sanjai  1 , Kunjukrishanpilla Sivaprasad  1 , Praveen Velappan  1 , Radhakrishnan Vellikat Velayudhan  1
Affiliations

Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum

Padmajan Sabin et al. Indian Heart J. 2017 Apr.

Abstract

Background: Primary angioplasty (PCI) for acute myocardial infarction is associated with no-reflow phenomenon, in about 5-25% of cases. Here we analysed the factors predicting no reflow .

Methods: This was a case control study of consecutive patients with acute myocardial infarction who underwent Primary PCI from August 2014 to February 2015.

Results: Of 181 patients who underwent primary PCI, 47 (25.9%) showed an angiographic no-reflow phenomenon. The mean age was 59.19±10.25years and females were 11%. Univariate predictors of no reflow were age >60years (OR=6.146, 95%CI 2.937-12.86, P=0<0.001), reperfusion time >6h (OR=21.94, 95%CI 9.402-51.2, P=<0.001), low initial TIMI flow (≤1) (OR=12.12, 95%CI 4.117-35.65, P<0.001), low initial TMPG flow (≤1) (OR=36.19, 95%CI 4.847-270.2, P<0.001) a high thrombus burden (OR=11.04,95%CI 5.124-23.8, P<0.001), a long target lesion (OR=8.54, 95%CI 3.794-19.23, P<0.001), Killip Class III/IV(OR=2.937,95%CI 1.112-7.756,P=0.025) and overlap stenting(OR=3.733,95%CI 1.186-11.75,P=0.017). Multiple stepwise logistic regression analysis predictors were: longer reperfusion time>6h (OR=13.844, 95%CI 3.214-59.636, P=<0.001), age >60 years (OR=8.886, 95%CI 2.145-36.80, P=0.003), a long target lesion (OR=8.637, 95%CI 1.975-37.768, P=0.004), low initial TIMI flow (≤1) (OR=20.861, 95%CI 1.739-250.290, P=0.017).

Conclusions: It is important to minimize trauma to the vessel, avoid repetitive balloon dilatations use direct stenting and use the shortest stent if possible.

Keywords: No-reflow; Predictors; Primary angioplasty.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The distribution of angiographic no-reflow, slow-flow and reflow in the study population.
Fig. 2
Fig. 2
The distribution of risk factors in the no-reflow and reflow groups.
Fig. 3
Fig. 3
Myocardial infarction types in the no-reflow and the reflow groups.
Fig. 4
Fig. 4
STR and in-hospital mortality in the reflow and no-reflow groups.
Fig. 5
Fig. 5
Independent predictors of the no-reflow phenomenon.
Fig. 6
Fig. 6
The forest plot for factors associated with no-reflow derived from univariate analysis of binary logistic regression.
Fig. 7
Fig. 7
The forest plot for factors associated with no-reflow derived from multivariate analysis of binary logistic regression.
See this image and copyright information in PMC

References

    1. Weawer W.D., Simes R.J., Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA. 1997;278:2093–2098. - PubMed
    1. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361:13–20. - PubMed
    1. Ito H., Okamura A., Iwakura K. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993–1999. - PubMed
    1. Reffelmann T., Kloner R.A. The no-reflow phenomenon: basic science and clinical correlates. Heart. 2002;87:162–168. - PMC - PubMed
    1. Bulluck H., Sirker, Loke Y.K., Garcia-Dorado D., Hausenloy D.J. Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevationmyocardial infarction patients: an updated meta-analysis of randomizedcontrolled trials. Int J Cardiol. 2016;201(202):228–237. - PMC - PubMed

MeSH terms